Published: 2019-07-23

Efficacy of pregabalin versus nortriptyline in the treatment of chronic low backache with radiculopathy: an open label observational study

Annapurna V. T., Nivedita Maity, Ravikumar T. V.


Background: The efficacy and safety of Pregabalin and Nortriptyline have been proved individually in low backache with radicular pain. However, there are limited number of studies comparing the efficacy of Pregabalin and Nortriptyline in Chronic Low Backache (CLBA) with radicular pain. Hence the present study was designed to determine the efficacy as well as tolerability of Pregabalin in comparison with that of Nortriptyline for reduction of pain in CLBA. The present study was an open label prospective observational study.

Methods: Patients with CLBA, 15-60 years of age without specific cause and significant neurological deficit were included in the study. Severity of pain was assessed by Visual Analogue Scale (VAS). Patients were followed up at 2 and 4 weeks and their VAS scores and side effects were noted.

Results: Both Pregabalin and Nortriptyline were effective in reducing pain, from baseline to 2 weeks and up to 4 weeks of treatment in chronic low backache with radicular pain, but there was no statistically significant difference between the two treatment groups. The incidences of side effects were less in the Nortriptyline treatment group as compared to Pregabalin.

Conclusions: From the results of the present study it can be concluded that both Pregabalin and Nortriptyline were equally effective in the treatment of chronic low backache with radicular pain, but the incidence of adverse effects were more with Pregabalin as compared to Nortriptyline.


Chronic low backache, Efficacy, Nortriptyline, Pregabalin, Tolerability

Full Text:



Sardar K, Das G, Mahta P, Mallick S, Hubbard R. Medical ozone in herniated disc: A classical review. J Pain Relief. 2014;3(3):1000148.

Nordin M, Balague F, Cedraschi C. Nonspecific low back pain surgical versus non-surgical treatment. Clinical orthopaedics and related research. Lippincott Williams and Willkins 2006;443:157-67.

Chou R, Qaseem A, Snow V, Casey D, Cross JT, Shekelle P, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007 Oct 2;147(7):478-91.

Kalita J, Kohat AK, Misra UK, Bhoi SK. An open labeled randomized controlled trial of pregabalin versus amitriptyline in chronic low backache. J Neurol Scie. 2014 Jul 15;342(1-2):127-32.

KD Tripathi. Textbook of Pharmacology. 8th ed. New Delhi: Jaypee brother’s medical publishers; 2019:446.

Katzung and Trevor. Special Aspects of Geriatric Pharmacology. Basic and Clinical Pharmacology. 13th ed. Mc Graw Hill; 2016:1054.

Freynhagen R, Baron R. The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep. 2009;13(3):185-90.

Orbai AM, Meyerhoff JO. The effectiveness of tricyclic antidepressants on lumbar spinal stenosis. Bull NYU Hosp Jt Dis. 2010 Jan 1;68(1):22-4.

Atkinson JH, Slater MA, Williams RA, Zisook S, Patterson TL, Grant I et al. A placebo controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain. 1998;76(3):287-96.

Max MB, Culnane M, Schafer SC, Gracely RH, Walther DJ, Smoller B, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 1987;37(4):589-96.